AUM and trading activity drives Oppenheimer's wealth management business. Read why we remain bullish on OPY stock.

YAVNE, Israel, Feb. 04, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics ...

Alphabet (GOOGL) will be stepping up to the earnings plate tomorrow (February 4), when it will deliver its fourth quarter ...

Over the years, we’ve heard hundreds of time about how we have enough nuclear weapons to destroy the world. But is that ...

About Y-mAbs Y-mAbs is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, radioimmunotherapy and antibody-based therapeutic cancer products. The ...

After the music industry gave out its prestigious Grammys Sunday, the film community is gearing up for its ceremony to take ...

Patient Capital Management stated the following regarding Coinbase Global, Inc. (NASDAQ:COIN) in its Q4 2024 investor letter: ...

Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is ...

Benny Safdie is the latest actor to join the cast of The Odyssey, the next movie from Christopher Nolan, according to The ...

Hulu has renewed the hit series Tell Me Lies for a third season, sharing on social media: “couldn’t keep you waiting any ...

Oppenheimer analysts adjusted their outlook on Spectrum Brands Holdings Inc . (NYSE: NYSE:SPB), reducing the price target from the previous $115.00 to $105.00. Despite the price target cut, the firm ...

Oppenheimer (NYSE:OPY – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a report issued on Monday. Oppenheimer Trading ...